Rhythm Pharm Rg
RYTM
USD
STOCK MARKET:
NMS
Open
 
...
Large gap with delayed quotes
Last quote
11/04/2025 - 20:20:09
Bid
11/04/2025 - 20:23:01
Bid
Volume 		Ask
11/04/2025 - 20:23:01
Ask
Volume
107.50
-6.24 ( -5.49% )
107.21
200
107.47
300
More information
Analysis by TheScreener
31.10.2025
Evaluation Slightly negative  
Interest Strong  
Sensibility High  
Analysis date: 31.10.2025
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 05.08.2025.
Interest
  Strong
Three stars since 14.10.2025.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 26.09.2025 at a price of 99.16.
Evaluation
  Strongly overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
  Positive
 
The dividend-adjusted forty day technical trend is positive since 15.07.2025.
4wk Rel Perf
  10.38%
 
The four-week dividend-adjusted overperformance versus SP500 is 10.38%.
Sensibility
  High
The stock has been on the high-sensitivity level since 15.07.2025.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -1.13%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 3.47%.
Mkt Cap in $bn
  7.56
With a market capitalization between $2 & $8bn, RHYTHM PHARMACEUTICALS is considered a mid-cap stock.
G/PE Ratio
  0.85
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  120.87
The estimated PE is for the year 2027.
LT Growth
  103.04%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  73
For 1% of index variation, the stock varies on average by 0.73%.
Correlation
  0.23
Stock movements are strongly independent of index variations.
Value at Risk
  60.23
The value at risk is estimated at USD 60.23. The risk is therefore 52.94%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  15.07.2025